Showing results (461-470 of 617) with videos related to
Sort By:
Pageof 62
The Journal of Pathology|February 20, 2014
KRAS (but not BRAF) mutations in ovarian serous borderline tumour are associated with recurrent low-grade serous carcinomaYvonne T Tsang, Michael T Deavers, Charlotte C Sun, et al.Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research|June 13, 2002
Axillary lymph node cellular immune response to HER-2/neu peptides in patients with carcinoma of the breastHenry M Kuerer, George E Peoples, Aysegul A Sahin, et al.International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|May 11, 2005
Heterogeneity of stage IIIA endometrial carcinomas: implications for adjuvant therapyB M Slomovitz, L M Ramondetta, C M Lee, et al.International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|October 12, 2024
TERT promoter mutations and survival outcomes in adult-type granulosa cell tumorsAllison L Brodsky, Alejandra Flores Legarreta, Bryan M Fellman, et al.Obstetrics and Gynecology|August 2, 2006
Clinical behavior of stage II-IV low-grade serous carcinoma of the ovaryDavid M Gershenson, Charlotte C Sun, Karen H Lu, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 24, 2006
Stress hormone-mediated invasion of ovarian cancer cellsAnil K Sood, Robert Bhatty, Aparna A Kamat, et al.Gynecologic Oncology|December 17, 2013
The prognostic significance of pre- and post-treatment CA-125 in grade 1 serous ovarian carcinoma: a gynecologic Oncology Group studyAmanda Nickles Fader, James Java, Thomas C Krivak, et al.Oncogene|October 14, 2004
An HSP90-mimic peptide revealed by fingerprinting the pool of antibodies from ovarian cancer patientsClaudia I Vidal, Paul J Mintz, Karen Lu, et al.Haematologica|December 7, 2005
Low prevalence of premature ovarian failure in women given reduced-intensity conditioning regimens for hematopoietic stem-cell transplantationYee Chung Cheng, Rima M Saliba, Gabriela Rondón, et al.Cancer Biology & Therapy|July 21, 2006
The BRK tyrosine kinase is expressed in high-grade serous carcinoma of the ovaryRosemarie E Schmandt, Marsha Bennett, Stephanie Clifford, et al.Pageof 62